Physician profile
Jill Botelho
NPI 1982894879
$2,226.57
in general payments reported to CMS, 2019-2025
20 companies · $196 in 2025
The $196 reported for 2025 was more than what a typical Obstetrics provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $232 · 2020: $90.62 · 2021: $184 · 2022: $142 · 2023: $281 · 2024: $1,101 · 2025: $196.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,000 · Food and Beverage: $485 · Education: $94.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,000.00 |
| Food and Beverage | $484.55 |
| Education | $94.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,000.00 | 2024 | |
| Astellas Pharma US INC | $266.05 | 2023-2025 | Veozah |
| Abbvie INC. | $240.07 | 2019-2025 | Liletta |
| Coopersurgical, INC. | $94.40 | 2019-2025 | Ally II Ups, Paragard T 380a |
| Therapeuticsmd, INC. | $77.15 | 2019-2021 | |
| Duchesnay USA Incorporated | $64.19 | 2019 | |
| Organon LLC | $56.83 | 2021-2023 | Nexplanon |
| Hologic Sales and Service, LLC | $55.93 | 2019-2021 | |
| Agile Therapeutics, INC. | $52.14 | 2021-2024 | Twirla |
| Mylan Pharmaceuticals INC. | $42.47 | 2020-2021 | |
| Pfizer INC. | $38.99 | 2020-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $35.45 | 2019-2023 | |
| Exact Sciences Corporation | $33.72 | 2025 | Cologuard Collection Kit |
| Mayne Pharma Commercial LLC | $33.48 | 2025 | |
| Sumitomo Pharma America, INC. | $28.25 | 2023 | Myfembree |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dexcom, INC. | $26.94 | 2025 | Dexcom G6 Transmitter |
| Roche Diagnostics Corporation | $26.16 | 2022 | |
| Scynexis, INC. | $19.64 | 2022 | |
| Merck Sharp & Dohme LLC | $17.74 | 2019 | |
| Mimedx Group, INC. | $16.97 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jill Botelho listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.